Ifp Advisors, Inc Neurocrine Biosciences Inc Transaction History

Ifp Advisors, Inc

$2.91 Billion
Q4 2024

A detailed history of Ifp Advisors, Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 2,020 shares of NBIX stock, worth $230,219. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,020

Previous 1,883 7.28%

Holding current value

$230,219

Previous $216,000 27.31%

% of portfolio

0.01%

Previous 0.01%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$111.62 - $139.44 $15,291 - $19,103	137 Added 7.28%	2,020 $275,000
Q3 2024 Feb 04, 2025	SELL	$114.58 - $153.15 $21,082 - $28,179	-184 Reduced 8.9%	1,883 $216,000
Q2 2024 Jul 30, 2024	SELL	$130.86 - $143.19 $57,578 - $63,003	-440 Reduced 17.55%	2,067 $284,000
Q1 2024 Jul 30, 2024	BUY	$130.4 - $143.74 $59,332 - $65,401	455 Added 22.17%	2,507 $345,000
Q4 2023 Jan 09, 2024	BUY	$106.07 - $132.76 $25,562 - $31,995	241 Added 13.31%	2,052 $270,000
Q3 2023 Oct 12, 2023	BUY	$94.02 - $117.1 $1,504 - $1,873	16 Added 0.89%	1,811 $203,000
Q2 2023 Aug 04, 2023	SELL	$89.53 - $104.87 $5,550 - $6,501	-62 Reduced 3.34%	1,795 $169,000
Q1 2023 Apr 18, 2023	SELL	$94.11 - $123.02 $8,375 - $10,948	-89 Reduced 4.57%	1,857 $187,000
Q4 2022 Feb 07, 2023	SELL	$106.72 - $127.06 $36,178 - $43,073	-339 Reduced 14.84%	1,946 $196,000
Q3 2022 Nov 08, 2022	BUY	$92.03 - $107.81 $52,181 - $61,128	567 Added 33.0%	2,285 $229,000
Q2 2022 Sep 06, 2022	BUY	$75.79 - $100.07 $130,207 - $171,920	1,718 New	1,718 $170,000
Q2 2022 Aug 12, 2022	SELL	$75.79 - $100.07 $130,207 - $171,920	-1,718 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$72.45 - $94.81 $16,011 - $20,953	221 Added 14.76%	1,718 $161,000
Q1 2022 Aug 08, 2022	BUY	$72.45 - $94.81 $1,014 - $1,327	14 Added 0.94%	1,497 $140,000
Q4 2021 Jan 12, 2022	BUY	$79.65 - $106.22 $955 - $1,274	12 Added 0.82%	1,483 $128,000
Q3 2021 Oct 06, 2021	SELL	$86.18 - $99.03 $3,705 - $4,258	-43 Reduced 2.84%	1,471 $141,000
Q2 2021 Jul 13, 2021	SELL	$89.43 - $102.27 $9,926 - $11,351	-111 Reduced 6.83%	1,514 $147,000
Q1 2021 Apr 30, 2021	BUY	$87.57 - $119.4 $17,076 - $23,283	195 Added 13.64%	1,625 $158,000
Q4 2020 Jan 25, 2021	BUY	$86.91 - $108.33 $36,502 - $45,498	420 Added 41.58%	1,430 $137,000
Q3 2020 Oct 29, 2020	BUY	$96.16 - $135.15 $85,582 - $120,283	890 Added 741.67%	1,010 $96,000
Q2 2020 Aug 05, 2020	BUY	$85.09 - $130.36 $850 - $1,303	10 Added 9.09%	120 $15,000
Q1 2020 May 12, 2020	SELL	$75.11 - $113.76 $1,727 - $2,616	-23 Reduced 17.29%	110 $10,000
Q4 2019 Jan 17, 2020	SELL	$86.8 - $118.57 $6,683 - $9,129	-77 Reduced 36.67%	133 $14,000
Q3 2019 Nov 07, 2019	BUY	$83.82 - $101.5 $8,382 - $10,150	100 Added 90.91%	210 $19,000
Q1 2019 May 15, 2019	SELL	$69.31 - $91.53 $14,347 - $18,946	-207 Reduced 65.3%	110 $10,000
Q4 2018 Jan 23, 2019	SELL	$68.32 - $124.36 $7,651 - $13,928	-112 Reduced 26.11%	317 $22,000
Q3 2018 Oct 25, 2018	BUY	$98.88 - $125.85 $11,074 - $14,095	112 Added 35.33%	429 $0
Q2 2018 Aug 07, 2018	BUY	$75.3 - $105.99 $8,057 - $11,340	107 Added 50.95%	317 $0
Q1 2018 Jun 03, 2019	SELL	$75.88 - $92.43 $531 - $647	-7 Reduced 3.23%	210 $16,000
Q1 2018 May 09, 2018	BUY	$75.88 - $92.43 $531 - $647	7 Added 3.33%	217 $0
Q4 2017 Jan 24, 2018	BUY	$58.53 - $77.59 $6,438 - $8,534	110 Added 110.0%	210 $0
Q2 2016 Jun 03, 2019	SELL	N/A	-10 Reduced 9.09%	100 $5,000
Q1 2016 Jun 03, 2019	BUY	N/A	110	110 $10,000

Others Institutions Holding NBIX

# of Institutions

652

Shares Held

96.5M

Call Options Held

282K

Put Options Held

281K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $10.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account